← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Joanneum Research Forschungsgesellschaft Mbh
Graz
$3,828,500
Total funding
3
Grants
Funding over time
peak $1M · FY2013–25$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$3,828,500 · 3
By mechanism
U01$3,828,500 · 3
Investigators at Joanneum Research Forschungsgesellschaft Mbh
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM$1,000,000
U01 · FY2018 · FD
Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics$500,000
U01 · FY2023 · FD
NOVEL METHODOLOGIES AND IVIVC APPROACHES TO ASSESS BIOEQUIVALENCE OF TOPICAL DRUG$500,000
U01 · FY2013 · FD
Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM$500,000
U01 · FY2016 · FD
Development of a Universal Bioequivalence Test Method for Topical Drugs using dOFM$500,000
U01 · FY2017 · FD
Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics$328,500
U01 · FY2025 · FD
NOVEL METHODOLOGIES AND IVIVC APPROACHES TO ASSESS BIOEQUIVALENCE OF TOPICAL DRUG$250,000
U01 · FY2014 · FD
Optimized clinical dermal Open Flow Microperfusion study design to demonstrate bioequivalence based on cutaneous pharmacokinetics$250,000
U01 · FY2022 · FD